Related Experiment Video
Updated: Jul 20, 2026

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
Meroparamycin production by newly isolated Streptomyces sp. strain MAR01: taxonomy, fermentation, purification and
Moustafa Y El-Naggar1, Samy A El-Assar, Sahar M Abdul-Gawad
1Botany Department, Microbiology Division, Faculty of Science, Alexandria University, Moharram Bay 21511, Alexandria, Egypt. moustafa64@yahoo.com
Abstract:
Twelve actinomycete strains were isolated from Egyptian soil. The isolated actinomycete strains were then screened with regard to their potential to generate antibiotics. The most potent of the producer strains was selected and identified. The cultural and physiological characteristics of the strain identified the strain as a member of the genus Streptomyces. The nucleotide sequence of the 16S rRNA gene (1.5 kb) of the most potent strain evidenced a 99% similarity with Streptomyces spp. and S. aureofaciens 16S rRNA genes, and the isolated strain was ultimately identified as Streptomyces sp. MAR01. The extraction of the fermentation broth of this strain resulted in the isolation of one major compound, which was active in vitro against gram-positive, gram-negative representatives and Candida albicans. The chemical structure of this bioactive compound was elucidated based on the spectroscopic data obtained from the application of MS, IR, UV, 1H NMR, 13C NMR, and elemental analysis techniques. Via comparison to the reference data in the relevant literature and in the database search, this antibiotic, which had a molecular formula of C19H29NO2 and a molecular weight of 303.44, was determined to differ from those produced by this genus as well as the available known antibiotics. Therefore, this antibiotic was designated Meroparamycin.
Insights
Researchers discovered a new antibiotic, Meroparamycin, from Egyptian soil actinomycetes. This potent compound exhibits broad-spectrum activity against bacteria and fungi.
Area of Science:
- Microbiology
- Natural Product Chemistry
Background:
- Actinomycetes are a prolific source of bioactive natural products.
- The discovery of novel antibiotics is crucial for combating antimicrobial resistance.
Purpose of the Study:
- To isolate and identify novel antibiotic-producing actinomycetes from Egyptian soil.
- To characterize and elucidate the structure of a newly discovered antibiotic.
Main Methods:
- Isolation and screening of actinomycete strains from soil samples.
- Identification of potent strains using cultural, physiological, and 16S rRNA gene sequencing.
- Antibiotic compound isolation via fermentation broth extraction.
- Structure elucidation using spectroscopic techniques (MS, IR, UV, NMR) and elemental analysis.
Main Results:
- Isolated twelve actinomycete strains, identifying one as Streptomyces sp. MAR01.
- Discovered a novel antibiotic, Meroparamycin (C19H29NO2), with a molecular weight of 303.44.
- Meroparamycin demonstrated in vitro activity against Gram-positive bacteria, Gram-negative bacteria, and Candida albicans.
Conclusions:
- Streptomyces sp. MAR01 produces a novel antibiotic, Meroparamycin.
- Meroparamycin represents a new class of antibiotic with potential therapeutic applications.
- Further research is warranted to explore the full potential of Meroparamycin.
Related Concept Videos
Production of Antibiotics
Bacterial Phylum Actinobacteria
Production of Organic Acids
Production of Pharmaceuticals
Clinical Significance of Antibiotic Resistance
Production of Alcohol

